TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/30/24 19:12 | 9/13/24 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | 3 | 4 | P | 40,616 | 19.32 | 0 | 2,103 | 153 | 3,473 | I | ||||||||||||||
6/12/24 18:28 | 6/12/24 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | 3 | 4 | P | 1,082 | 25.15 | 0 | 43 | 97 | 87 | D | |||||||||||||||
5/16/24 20:02 | 5/16/24 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | 2 | 2 | P | 78 | 1.92 | 0 | 41 | 2 | 2,184 | I | ||||||||||||||
3/19/24 17:29 | 3/18/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | 1 | 2 | P.d | 136 | 26.41 | 0 | 5 | 68 | 13 | D | ||||||||||||||
3/5/24 17:15 | 3/1/24 | PSNL | Personalis, Inc. | DE | Health | Health | Medical Laboratories | 1 | 1 | P | 17 | 1.67 | 0 | 10 | 62 | 26 | D | ||||||||||||||
8/23/23 18:56 | 5/30/23 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | 1 | 6 | P.m | 466 | 1.41 | 0 | 329 | 1 | 30,708 | I | ||||||||||||||
6/6/23 16:48 | 6/5/23 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | 1 | 1 | P | 69 | 14.38 | 0 | 5 | 113 | 9 | D | ||||||||||||||
5/24/23 16:32 | 5/22/23 | CELC | Celcuity Inc. | DE | Health | Health | Medical Laboratories | 1 | 1 | P.d | 103 | 10.32 | 0 | 10 | 999% | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |